OBJECTIVES: Diet plays a crucial role in the development of obesity and insulin resistance via multiple mechanisms. Saturated fatty acids can directly trigger tissue specific proinflammatory pathways via Toll-like receptor-4 (TLR4)-dependent mechanisms. Moreover, diet can change the gut microbiome and increase gut permeability. However, very few studies have addressed the obesity-independent role of diet. Dissecting the effects of diet from those of obesity per se will enhance our understanding of the underlying pathogenesis, and, at the translational level, advance our treatment approaches for obesity and its co-morbidities. METHODS: Melanin-concentrating hormone (MCH) is an important regulator of appetite and energy balance. MCH-deficient mice are resistant to diet-induced obesity, primarily due to increased locomotor activity. We took advantage of the unique phenotype of these mice to examine the metabolic and inflammatory consequences of a 15-week consumption of a diet high in saturated fat. RESULTS: MCH-deficient mice chronically exposed to a high-fat diet gain less weight compared to their wild-type littermates, despite similar food intake, and are protected from hepatosteatosis. They also lack obesity-associated upregulation of serum leptin and insulin levels and have improved total body insulin sensitivity. Nevertheless, we found indistinguishable liver-specific innate immune responses in both genotypes associated with high-fat feeding, which involved activation of TLR4 and its downstream effectors, MyD88, p38 MAP kinase and STAT-3. CONCLUSIONS: Our findings indicate that high-fat feeding is deleterious to the liver, independently of the obesity status. They also suggest that MCH is not necessary for the TLR4-dependent immune response triggered by the high-fat diet.
OBJECTIVES: Diet plays a crucial role in the development of obesity and insulin resistance via multiple mechanisms. Saturated fatty acids can directly trigger tissue specific proinflammatory pathways via Toll-like receptor-4 (TLR4)-dependent mechanisms. Moreover, diet can change the gut microbiome and increase gut permeability. However, very few studies have addressed the obesity-independent role of diet. Dissecting the effects of diet from those of obesity per se will enhance our understanding of the underlying pathogenesis, and, at the translational level, advance our treatment approaches for obesity and its co-morbidities. METHODS: Melanin-concentrating hormone (MCH) is an important regulator of appetite and energy balance. MCH-deficientmice are resistant to diet-induced obesity, primarily due to increased locomotor activity. We took advantage of the unique phenotype of these mice to examine the metabolic and inflammatory consequences of a 15-week consumption of a diet high in saturated fat. RESULTS:MCH-deficientmice chronically exposed to a high-fat diet gain less weight compared to their wild-type littermates, despite similar food intake, and are protected from hepatosteatosis. They also lack obesity-associated upregulation of serum leptin and insulin levels and have improved total body insulin sensitivity. Nevertheless, we found indistinguishable liver-specific innate immune responses in both genotypes associated with high-fat feeding, which involved activation of TLR4 and its downstream effectors, MyD88, p38 MAP kinase and STAT-3. CONCLUSIONS: Our findings indicate that high-fat feeding is deleterious to the liver, independently of the obesity status. They also suggest that MCH is not necessary for the TLR4-dependent immune response triggered by the high-fat diet.
Authors: D S Ludwig; N A Tritos; J W Mastaitis; R Kulkarni; E Kokkotou; J Elmquist; B Lowell; J S Flier; E Maratos-Flier Journal: J Clin Invest Date: 2001-02 Impact factor: 14.808
Authors: Dongsheng Cai; Minsheng Yuan; Daniel F Frantz; Peter A Melendez; Lone Hansen; Jongsoon Lee; Steven E Shoelson Journal: Nat Med Date: 2005-01-30 Impact factor: 53.440
Authors: Yuan Zhai; Xiu-da Shen; Ryan O'Connell; Feng Gao; Charles Lassman; Ronald W Busuttil; Genhong Cheng; Jerzy W Kupiec-Weglinski Journal: J Immunol Date: 2004-12-15 Impact factor: 5.422
Authors: Susan E Schadinger; Nancy L R Bucher; Barbara M Schreiber; Stephen R Farmer Journal: Am J Physiol Endocrinol Metab Date: 2005-01-11 Impact factor: 4.310
Authors: D Qu; D S Ludwig; S Gammeltoft; M Piper; M A Pelleymounter; M J Cullen; W F Mathes; R Przypek; R Kanarek; E Maratos-Flier Journal: Nature Date: 1996-03-21 Impact factor: 49.962
Authors: Omar Al-Massadi; Mar Quiñones; Jerome Clasadonte; René Hernandez-Bautista; Amparo Romero-Picó; Cintia Folgueira; Donald A Morgan; Imre Kalló; Violeta Heras; Ana Senra; Samuel C Funderburk; Michael J Krashes; Yara Souto; Miguel Fidalgo; Serge Luquet; Melissa J Chee; Monica Imbernon; Daniel Beiroa; Lucía García-Caballero; Rosalia Gallego; Brian Y H Lam; Giles Yeo; Miguel Lopez; Zsolt Liposits; Kamal Rahmouni; Vincent Prevot; Carlos Dieguez; Ruben Nogueiras Journal: Diabetes Date: 2019-09-16 Impact factor: 9.461
Authors: Monica Imbernon; Daniel Beiroa; María J Vázquez; Donald A Morgan; Christelle Veyrat-Durebex; Begoña Porteiro; Adenis Díaz-Arteaga; Ana Senra; Silvia Busquets; Douglas A Velásquez; Omar Al-Massadi; Luis Varela; Marina Gándara; Francisco-Javier López-Soriano; Rosalía Gallego; Luisa M Seoane; Josep M Argiles; Miguel López; Roger J Davis; Guadalupe Sabio; Françoise Rohner-Jeanrenaud; Kamal Rahmouni; Carlos Dieguez; Ruben Nogueiras Journal: Gastroenterology Date: 2012-11-06 Impact factor: 22.682
Authors: Omar Al-Massadi; Carlos Dieguez; Marc Schneeberger; Miguel López; Markus Schwaninger; Vincent Prevot; Ruben Nogueiras Journal: Nat Rev Endocrinol Date: 2021-10-04 Impact factor: 47.564
Authors: Eva Prida; Sara Fernández-González; Verónica Pena-León; Raquel Pérez-Lois; Johan Fernø; Luisa María Seoane; Mar Quiñones; Omar Al Massadi Journal: Int J Mol Sci Date: 2022-02-23 Impact factor: 5.923